Characterization of two in vivo-expressesd methyltransferases of the Mycobacterium tuberculosis complex: Antigenicity and genetic regulation

Microbiology

Volumn 154, Issue 4, 2008, Pages 1059-1067

  Golby, Paul ^a   Nunez, Javier ^a   Cockle, Paul J ^a   Ewer, Katie ^a   Logan, Karen ^a,c   Hogarth, Philip ^a   Vordermeier, H Martin ^a   Hinds, Jason ^b   Hewinson, R Glyn ^a   Gordon, Stephen V ^a,d  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c Emergent Biosolutions   (United Kingdom)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLTRANSFERASE; MYCOBACTERIUM ANTIGEN; REGULATOR PROTEIN; TRANSCRIPTOME; BACTERIAL ANTIGEN; BACTERIAL PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; ARTICLE; CATTLE DISEASE; CONTROLLED STUDY; DELETION MUTANT; ENZYME ANALYSIS; FEMALE; GENE CONSTRUCT; GENE EXPRESSION PROFILING; GENETIC CODE; GENETIC REGULATION; GENETIC SCREENING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; BIOSYNTHESIS; CATTLE; DNA MICROARRAY; ENZYMOLOGY; GENE DELETION; GENE EXPRESSION REGULATION; IMMUNOLOGY; MYCOBACTERIUM BOVIS; REGULATOR GENE; TUBERCULOSIS;

BOS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CATTLE; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENES, REGULATOR; METHYLTRANSFERASES; MICE; MUTAGENESIS, INSERTIONAL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUBERCULOSIS; TUBERCULOSIS, BOVINE; UP-REGULATION;

EID: 44349115626     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.2007/014548-0     Document Type: Article

References (23)

1. Bacon, J, James, B. W., Wernisch, L., Williams, A., Morley, K. A., Hatch, G. J., Mangan, J. A., Hinds, J., Stoker, N. G. & other authors (2004). The influence of reduced oxygen availability on pathogenicity and gene expression in Mycobacterium tuberculosis. Tuberculosis (Edinb) 84, 205-217.
2. Cockle, P. J., Gordon, S. V., Lalvani, A., Buddle, B. M., Hewinson, R. G. & Vordermeier, H. M. (2002). Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. Infect Immun 70, 6996-7003.
3. Cole, S. T., Brosch, R., Parkhill, J., Gamier, T., Churcher, C., Harris, D., Gordon, S. V., Eigimeier, K., Gas, S. & other authors (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544.
4. Donnelly-Wu, M. K., Jacobs, W. R., Jr & Hatfull, G. F. (1993). Superinfection immunity of mycobacteriophage L5: applications for genetic transformation of mycobacteria. Mol Microbiol 7, 407-417.
5. Ellison, D. W. & Miller, V. L. (2006). Regulation of virulence by members of the MarR/SlyA family. Curr Opin Microbiol 9, 153-159.
6. Gamier, T., Eigimeier, K., Camus, J. C., Medina, N., Mansoor, H., Pryor, M., Duthoy, S., Grondin, S., Lacroix, C. & other authors (2003). The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci U S A 100, 7877-7882.
7. Glickman, M. S, Coy, J. S. & Jacobs, W. R., Jr (2000). A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis, Mol Cell 5, 717-727.
8. Golby, P., Hatch, K. A., Bacon, J., Cooney, R., Riley, P., Allnutt, J., Hinds, J., Nunez, J., Marsh, P. D. & other authors (2007). Comparative transcriptomics reveals key gene expression differences between the human and bovine pathogens of the Mycobacterium tuberculosis complex. Microbiology 153, 3323-3336.
9. Grkovic, S., Brown, M. H. & Skurray, R. A. (2002). Regulation of bacterial drug export systems. Microbiol Mol Biol Rev 66, 6717-701.
10. Ibanga, H. B., Brookes, R. H., Hill, P. C., Owiafe, P. K., Fletcher, H. A., Lienhardt, C., Hill, A. V., Adegbola, R. A. & McShane, H. (2006). Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design. Lancet Infect Dis 6, 522-528.
11. Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C. & Stover, C. K. (1996). Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178, 1274-1282.
12. Muttucumaru, D. G., Roberts, G., Hinds, J., Stabler, R. A. & Parish, T. (2004). Gene expression profile of Mycobacterium tuberculosis in a non-replicating state. Tuberculosis (Edinb) 84, 239-246.
13. Orme, I. M. (2006). Preclinical testing of new vaccines for tuberculosis: a comprehensive review. Vaccine 24, 2-19.
14. Pethe, K., Alonso, S., Biet, F., Delogu, G., Brennan, M. J., Locht, C. & Menozzi, F. D. (2001). The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 412, 190-194.
15. Pethe, K., Bifani, P., Drobecq, H., Sergheraert, C., Debrie, A. S., Locht, C. & Menozzi, F. D. (2002). Mycobacterial heparin-binding hemagglutinin and laminin-binding protein share antigenic methyllyines that confer resistance to: proteolysis. Proc Natl Acad Sci U S A 99, 10759-10764.
16. Rao, V., Gao, F., Chen, B., Jacobs, W. R., Jr & Glickman, M. S. (2006). Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence. J Clin Invest 116, 1660-1667.
17. Sassetti, C. M. & Rubin, E. J. (2003). Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A 100, 12989-12994.
18. Skjøt R. L., Oettinger, T., Rosenkrands, I., Ravn, P., Brock, L, Jacobsen, S. & Andersen, P. (2000). Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family ds immunodominant T-cell antigens. Infect Immun 68, 214-220.
19. Sorensen, A. L., Nagai, S., Houen G., Andersen, P. & Andersen, A. B. (1995). Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 63, 1710-1717.
20. Stinear, T. P., Seemann, T., Pidot, S., Frigui, W., Reysset, G., Garnier, T., Meurice, G., Simon, D., Bouchier, C. & other authors (2007). Reductive evolution and niche adaptation inferred from the genome of Mycobactenum ulcerans, the causative agent of Buruli ulcer. Genome Res 17, 192-200.
21. Temmerman, S., Pethe, K., Parra, M., Alonso, S., Rouanet C., Pickett, T., Drowart, A., Debrie, A. S,, Delogu, G. & other authors (2004). Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin. Nat Med 10, 935-941.
22. Vordermeier, H. M., Chambers, M. A., Buddle, B. M., Pollock, J. M. & Hewinson, R. G. (2006). Progress in the development of vaccines and diagnostic reagents to control. tuberculosis in cattle. Vet J 171, 229-244.
23. Voskull, M. I., Visconti, K C. & Schoolnik, G. K. (2004). Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis (Edinb) 84, 218-227.